Retatrutide
An investigational medicine that targets GIP, GLP-1 and glucagon receptors.
Uses: Being studied for obesity and related metabolic conditions. It is not FDA-approved; safety and effectiveness for routine treatment are not established.
Read medical reference ↗Retatrutide
Choose your package length.
| Package | Total price | Monthly equivalent |
|---|---|---|
| $220 | $220/mo | |
| $630 | $210/mo | |
| $1,200 | $200/mo |
Select a package above.